Atlas Genetics raises $20 mln Series C funding
Atlas Genetics, which develops diagnostic tests for infectious diseases, has raised $20 million in Series C funding from an investor group including new investor RMI Partners. Existing investors include Novartis Venture Funds, Consort Medical plc, Johnson & Johnson Innovation -- JJDC, Inc., LSP, BB Biotech Ventures and South West Ventures Fund. Atlas Genetics previously raised $25 million in Series B funding.
29 January 2015•5 mins read
